AVEO Pharmaceuticals, Inc. [NASDAQ: AVEO] opened at $0.7658 and closed at $0.76 a share within trading session on Dec 3, 2019. That means that the stock dropped by -2.78% compared to the closing price from a day before, when the stock touched $0.74.

Between the start and the closing of the latest trading session, AVEO Pharmaceuticals, Inc. [NASDAQ: AVEO] had 1.05 million shares being bought and sold. In the last three months, average trading volumes hovered around 2.85M shares. During the last week, volatility in the share price was set at 7.81%, which placed the metric for the last 30 days at 10.05%. The price of the stock additionally went down to $0.47 during that period and AVEO managed to take a rebound to $2.19 in the last 52 weeks.

AVEO Pharmaceuticals, Inc. [NASDAQ:AVEO]: Analyst Rating and Earnings

Its stock price has been found in the range of 0.47 to 2.19. This is compared to its latest closing price of $0.76.

Stay on the lookout for the next publication of this organization’s financial results for the quarter, which will be made public on Tue 12 Nov (21 days ago).

Fundamental Analysis of AVEO Pharmaceuticals, Inc. [AVEO]

Now let’s turn

to look at profitability: with a current Operating Margin for AVEO Pharmaceuticals, Inc. [AVEO] sitting at -481.12.

Similarly, its Total Debt to Total Assets stands at 68.13.

What about valuation? This company’s Enterprise Value to EBITDA is -4.49. The Enterprise Value to Sales for this firm is now 3.96, and its Total Debt to Enterprise Value stands at 0.09.

Shifting the focus to workforce efficiency, AVEO Pharmaceuticals, Inc. [AVEO] earns $318,176 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 3.16 and its Total Asset Turnover is 0.14. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 1.54 and its Current Ratio is 1.54. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

AVEO Pharmaceuticals, Inc. [AVEO] has 160.74M shares outstanding, amounting to a total market cap of $122.20M. Its stock price has been found in the range of 0.47 to 2.19. At its current price, it has moved down by -66.25% from its 52-week high, and it has moved up 57.52% from its 52-week low.

This stock’s Beta value is currently 0.66, which indicates that it is 7.81% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 55.21. This RSI score is good, suggesting this stock is neither overbought or oversold.

Conclusion: Is AVEO Pharmaceuticals, Inc. [AVEO] a Reliable Buy?

Shares of AVEO Pharmaceuticals, Inc. [AVEO], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.